Search / Trial NCT00002275

A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)

Launched by ABBOTT · Aug 30, 2001

Trial Information

Current as of December 26, 2024

Completed

Keywords

Weight Loss Pneumonia, Pneumocystis Carinii Parenteral Nutrition Liposyn Acquired Immunodeficiency Syndrome

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Concurrent Medication:
  • Allowed:
  • All drugs used for the standard treatment of Pneumocystis carinii pneumonia (PCP).
  • Other drugs for treatment of other AIDS conditions if they have been started more than 3 months prior to study entry.
  • Patients must have:
  • Diagnosis of AIDS.
  • Weight loss \> 10 percent of premorbid body weight.
  • First or second episode of acute Pneumocystis carinii pneumonia (PCP).
  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with the following conditions or symptoms are excluded:
  • Do Not Resuscitate (DNR) status.
  • Biliary stasis.
  • Patients with the following are excluded:
  • Do Not Resuscitate (DNR) status.
  • Biliary stasis.
  • Prior Medication:
  • Excluded within 3 months of study entry:
  • Immunomodulators.
  • Antiviral new DT

About Abbott

Abbott is a global healthcare company dedicated to improving lives through innovative medical technologies, diagnostics, nutrition, and branded generic pharmaceuticals. With a commitment to advancing health and wellness, Abbott conducts clinical trials to evaluate the safety and efficacy of its diverse portfolio of products, which span multiple therapeutic areas, including cardiovascular, diabetes care, and neurology. The company employs rigorous research methodologies and collaborates with healthcare professionals and institutions worldwide to ensure the highest standards of clinical integrity and patient safety. Abbott's mission is to deliver impactful solutions that enhance patient outcomes and contribute to the advancement of global healthcare.

Locations

East Orange, New Jersey, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials